Ibudol Pediátrico (Ibuprofen)

Ibudol Pediátrico (ibuprofen) is an NSAID that reduces inflammation and pain in pediatric patients.

• Mild to moderate pain: provides effective analgesic relief for common childhood aches such as toothache, sore throat, headache, or minor injuries.
• Fever: lowers elevated body temperature associated with viral or bacterial infections, post‑vaccination reactions, or other febrile illnesses in children.
• Inflammatory conditions: helps control swelling, pain and limited movement in pediatric inflammatory disorders such as juvenile idiopathic arthritis or transient synovitis.
• Post‑operative discomfort: reduces pain and inflammation after minor surgical procedures in children.

• Ibuprofen exerts its effect by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2. This blockade reduces the conversion of arachidonic acid to prostaglandins, which are mediators of inflammation, pain and fever. The decreased prostaglandin synthesis leads to lowered peripheral sensitization and central temperature set‑point, providing analgesic, antipyretic and anti‑inflammatory actions. The inhibition is reversible and dose‑dependent, allowing temporary modulation of the inflammatory cascade without permanent enzyme alteration.

Ibudol Pediátrico may cause adverse reactions typical of ibuprofen in pediatric patients.

Common Side Effects

• Stomach upset: nausea, abdominal discomfort or dyspepsia.
• Headache: mild to moderate headache may occur.
• Diarrhea: loose stools or increased bowel movements.
• Rash: mild skin erythema or itching.
• Dizziness: feeling light‑headed or unsteady.
• Vomiting: occasional emesis after dosing.

Serious or Rare Side Effects

• Gastrointestinal bleeding: vomiting blood or black stools indicating ulceration.
• Severe allergic reaction: swelling of face, lips, tongue, or difficulty breathing (anaphylaxis).
• Kidney impairment: reduced urine output or swelling indicating renal dysfunction.
• Liver injury: jaundice, elevated liver enzymes.
• Blood disorders: unexplained bruising or low platelet count.

When prescribing Ibudol Pediátrico, healthcare professionals should observe the following precautions.

• Age limitation: use only in children for whom ibuprofen is approved, typically from 6 months onward.
• Gastrointestinal risk: avoid in patients with active ulcers, severe gastritis, or history of GI bleeding.
• Cardiovascular caution: use cautiously in children with congenital heart disease or hypertension.
• Renal function: monitor kidney function in dehydrated children or those with pre‑existing renal impairment.
• Concomitant medications: assess for use with other NSAIDs, anticoagulants, or corticosteroids.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• High‑dose aspirin: heightened gastrointestinal toxicity.
• Selective COX‑2 inhibitors: additive renal and cardiovascular adverse effects.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function.
• Diuretics: potential for reduced diuretic efficacy and renal compromise.
• Lithium: ibuprofen can increase lithium serum levels, risking toxicity.